UBS Group’s COVA Acquisition Corp. Unit COVAU Stock Holding History

UBS Group’s Portfolio COVAU Stock Details COVAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-733	Closed	-$7K	–	11651
2022 Q3	$7K	Sell	733 -930	-56%	-$9.21K	﹤0.01%	8964
2022 Q2	$16K	Buy	1,663 +250	+18%	+$2.47K	﹤0.01%	7254
2022 Q1	$14K	Hold	1,413	–	–	﹤0.01%	8007
2021 Q4	$14K	Sell	1,413 -240	-15%	-$2.4K	﹤0.01%	8398
2021 Q3	$16K	Buy	1,653 +111	+7%	+$1.11K	﹤0.01%	7462
2021 Q2	$16K	Buy	+1,542	New	+$15.5K	﹤0.01%	7608

UBS Group's COVAU Position: Q4 2022 in Review

UBS Group sold out of COVA Acquisition Corp. Unit (COVAU) in Q4 2022, closing a stake of 733 shares — an estimated $7K sold.

UBS Group first reported a position in COVAU in Q2 2021 and held it in 6 quarters. The position peaked at $16K in Q2 2022. 0 funds tracked by Wall St. Rank hold COVAU as of Q4 2022.

UBS Group reported no remaining COVA Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
UBS Group sold 733 COVA Acquisition Corp. Unit shares in Q4 2022, an estimated $7K.
UBS Group first reported a position in COVA Acquisition Corp. Unit in Q2 2021 and held it in 6 quarters.
UBS Group's COVA Acquisition Corp. Unit position peaked at $16K in Q2 2022.
0 funds tracked by Wall St. Rank held COVA Acquisition Corp. Unit as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.